Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancers receiving moderately emetogenic chemotherapy regimens

Autor:	A. Pong, S. Khanani, Cindy Weinstein, Karin Jordan, Stephen J. Noga, Bernardo Leon Rapoport, Stuart A. Green, Waldimir Vallejos, Elizabeth Beckford-Brathwaite
Rok vydání:	2018
Předmět:	medicine.medical_specialty Oncology business.industry Internal medicine Obstetrics and Gynecology Medicine In patient business Gastroenterology Emetogenic chemotherapy Fosaprepitant medicine.drug Chemotherapy-induced nausea and vomiting
Zdroj:	Gynecologic Oncology. 149:161-162
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2018.04.370
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::dad35871819c3a9194bf5b2dbddd0860 https://doi.org/10.1016/j.ygyno.2018.04.370 Zobrazit plný text záznamu Full Text from ScienceDirect